Raziel Therapeutics

Israel
Reẖovot, Central District, Israel

Company profile

Raziel Therapeutics company profile

Raziel Therapeutics is a pharmaceutical company that develops an injectable treatment. They develop RZL-012, which is designed to be injected into subcutaneous fat and results in a considerable and long-lasting reduction in fat volume. Raziel is currently conducting a number of clinical trials for various fat issue indications as well as aesthetics.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2012-12-01

Headquarters

Country code
IL
Continent
Asia

Capital profile

Funding and company signals

Funding rounds
3
Total equity funding
$22.2M
Last funding
Series Unknown / $212,000 / 2025-10-01
Last equity funding
Series Unknown / $212,000
Investors
7
Lead investors
2
Founders
1
Articles
3

Founders and investors

Founders

Alon Bloomenfeld

Lead investors

PontifaxQuark Venture

Investors

Catalyst Fund LPPeregrine VenturesPontifaxQuark VentureWille Finance